| pubmed-article:18568700 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C0149721 | lld:lifeskim |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C0033105 | lld:lifeskim |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C1514468 | lld:lifeskim |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C0442726 | lld:lifeskim |
| pubmed-article:18568700 | lifeskim:mentions | umls-concept:C0857121 | lld:lifeskim |
| pubmed-article:18568700 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:18568700 | pubmed:dateCreated | 2008-6-23 | lld:pubmed |
| pubmed-article:18568700 | pubmed:abstractText | Detection and treatment of left ventricular hypertrophy (LVH) in hypertension is important in order to reduce cardiovascular risk. The product of QRS voltage and duration (e.g. Cornell voltage-duration product; CorP), is a good marker of LVH and the current study was designed to determine the prevalence of LVH in patients with essential hypertension treated in general practice. | lld:pubmed |
| pubmed-article:18568700 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18568700 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18568700 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18568700 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18568700 | pubmed:issn | 0803-7051 | lld:pubmed |
| pubmed-article:18568700 | pubmed:author | pubmed-author:BarriosVivenc... | lld:pubmed |
| pubmed-article:18568700 | pubmed:author | pubmed-author:EscobarCarlos... | lld:pubmed |
| pubmed-article:18568700 | pubmed:author | pubmed-author:CalderonAlber... | lld:pubmed |
| pubmed-article:18568700 | pubmed:author | pubmed-author:RibasLeandreL | lld:pubmed |
| pubmed-article:18568700 | pubmed:author | pubmed-author:MartiDavidD | lld:pubmed |
| pubmed-article:18568700 | pubmed:author | pubmed-author:AsinEnriqueE | lld:pubmed |
| pubmed-article:18568700 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18568700 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:18568700 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18568700 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18568700 | pubmed:pagination | 110-5 | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:meshHeading | pubmed-meshheading:18568700... | lld:pubmed |
| pubmed-article:18568700 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18568700 | pubmed:articleTitle | Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population. | lld:pubmed |
| pubmed-article:18568700 | pubmed:affiliation | Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain. vbarriosa@meditex.es | lld:pubmed |
| pubmed-article:18568700 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18568700 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18568700 | pubmed:publicationType | Multicenter Study | lld:pubmed |
